Merck & Co. Inc. buy Cantor Fitzgerald
Start price
05.02.24
/
50%
€117.60
Target price
05.02.25
€125.66
Performance (%)
-8.14%
Price
16:12
€106.60
Summary
This prediction is currently active. With a performance of -8.14%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. A total of €1.42 was paid as dividends for this prediction. This prediction currently runs until 05.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 1.143% | 1.143% |
iShares Core DAX® | 2.147% | 2.681% |
iShares Nasdaq 100 | -0.578% | -0.816% |
iShares Nikkei 225® | 0.635% | 3.079% |
iShares S&P 500 | 0.746% | 0.171% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $135.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€102.20
23.08.23
23.08.23
€124.92
23.08.24
23.08.24
1.76%
24.08.24
24.08.24